Ascendia Pharma to Conduct Virtual Meetings During DCAT Week

Ascendia Pharma will be hosting virtual meetings during DCAT Week, from July 12-16. We look forward to having discussions with innovative bio/pharmaceutical companies, as well as generic drug and biosimilar companies to discover how we can be your CDMO partner. Contact us today to schedule a conversation with our management and scientific teams.  

How We Help Clients

As a specialty pharmaceutical CDMO, we develop tailored formulation solutions to ensure a rapid, successful transition of compounds from preclinical to the clinic. We have a proven track record of providing custom sterile- and non-sterile-enabling formulations, along with analytical methods for new chemical entities, complex dosage forms, and 505(B)(2) product development, as well as OTCs and nutraceuticals.

Learn About Our BEST Philosophy

Schedule a meeting with us to learn how our BEST philosophy – Brilliant technology, Excellent service, Superior quality, and Trust – can help you meet your timelines and stay within budget by making the insoluble soluble. We will explain how our suite of proprietary nanoparticle technologies – NanoSol^® (nanosuspension), AmorSol^® (amorphous nanoparticles), and EmulSol^® (nanoemulsion) – will help overcome your most complex drug development obstacles. Our experienced team can develop all dosage forms for new product development and GMP clinical trial materials (CTM).

Tell Us Your Goals – We’ll Help You Achieve Them

Let’s talk about your goals and objectives, from drug development and market penetration to corporate growth. We will then work with you to execute rapid, comprehensive, and cost-effective programs to help you achieve them by providing development and analytical testing services.

Schedule An Appointment Today

If you are in the bio/pharmaceutical manufacturing value chain, we look forward to engaging with you. Let’s discuss how we can partner with you to meet your drug development pipeline needs. Reserve a meeting with our management team by sending us an email at bd@ascendiapharma.com or call us at 732.640.0058.